Clinical Trials Logo

Primary Insomnia clinical trials

View clinical trials related to Primary Insomnia.

Filter by:

NCT ID: NCT05830877 Recruiting - Primary Insomnia Clinical Trials

The Study on the Evaluation of Acupuncture Therapy on Primary Insomnia

Start date: May 10, 2023
Phase: N/A
Study type: Interventional

Through the recruition of outpatients who clinically meet the diagnostic criteria and inclusion criteria of PI, the acupuncture group adopts Tiaoshen acupuncture, and the placebo acupuncture group adopts non-insertive acupuncture supported by the Park device, and the Pittsburgh Sleep Quality Index (PSQI) is used as the main index to evaluate the patients through the scale; subjective indicators like Chalder 14-item fatigue scale, Epworth sleepiness rating, self-rating anxiety scale (SAS), self-rating depression scale (SDS) and objective indicators like polysomnography (PSG), heart rate variability (HRV) is regarded as a secondary index, and then evaluate the clinical efficacy of Tiaoshen acupuncture on PI and explore its mechanism.

NCT ID: NCT05420090 Completed - Primary Insomnia Clinical Trials

The Effects of Milk and Banana as a Night Meal to Primary Insomnia on Sleep Quality, BDNF and Appetite Mechanism

diet
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study to determine the impact of banana and milk on sleep and appetite

NCT ID: NCT05416346 Completed - Primary Insomnia Clinical Trials

Digital Cognitive Behavioral Therapy for Insomnia in China

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

Digital cognitive behavioral therapy for insomnia (dCBT-i) is found to be effective but is rarely used in China. Hence, the investigators developed an automated Chinese dCBT-i program and examined its feasibility, acceptability, and preliminary effectiveness in individuals with insomnia symptoms.

NCT ID: NCT03542396 Completed - Depression Clinical Trials

Evaluation of a Group Therapeutic Exercise Program

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Moderate to vigorous physical activity can reduce symptoms of mental disorders like major depression, anxiety disorders, insomnia, and ADHD. However, in Germany there are no group therapeutical exercise programs for psychotherapy patients in an outpatient context. The current study aims to examine the effectiveness of a manualized exercise program, named ImPuls, which consists of a supervised and non-supervised endurance training in moderate to vigorous intensity and behaviour change techniques.

NCT ID: NCT03461666 Terminated - Primary Insomnia Clinical Trials

Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia

CEBATI
Start date: September 5, 2018
Phase: N/A
Study type: Interventional

This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I); Focus of Attention (FOA); Combined CBT-I and FOA; and Sleep Hygiene (control group) for the treatment of insomnia. This study is a randomized, open label study, and the participants are asked to assess the benefits they get from the intervention. This study involve 6 weekly in person one-to-one sessions after screening and completion of the 1-week, 3-month, 6-month and 12-month follow-up assessment. The trained study staff will administering the treatment. The Research Department will administer the outcome measures. The review of insomnia improvement will be assessed at at end of treatment, 3 months, 6 months and 12 months follow-up.

NCT ID: NCT03314441 Completed - Primary Insomnia Clinical Trials

Effects of Regular Practice of Yoga on Subjective and Objective Sleep Quality in Primary Insomnia

Start date: November 8, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the effects of regular Viniyoga in patients suffering from primary insomnia.

NCT ID: NCT02832804 Completed - Primary Insomnia Clinical Trials

Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients

Start date: February 2016
Phase: N/A
Study type: Interventional

To evaluate the clinical efficacy and safety of neuromodulation by transcranial direct current stimulation (tDCS) in the patients with primary chronic insomnia .

NCT ID: NCT02694003 Active, not recruiting - Clinical trials for Neurodevelopmental Disorders

Better Nights, Better Days for Children With Neurodevelopment Disorders

BNBD-NDD
Start date: June 10, 2019
Phase: N/A
Study type: Interventional

More than 90% of children with neurodevelopmental disorders (NDD) experience sleep problems, whereas less than 25% of typically developing children experience sleep problems. Poor sleep can have significant consequences for children's physical and psychosocial health, as well their caregivers' well-being. The impact of sleep problems on daytime functioning is even greater in children with NDD. Although there are a range of factors that may disturb sleep in children with NDD, the most frequent cause of sleep disturbance is behavioural insomnia. There is some evidence that behavioural interventions can be effective in improving sleep in children with NDD. However, this has not been tested through well-designed, large-scale randomized controlled trials (RCTs). Moreover, there are a number of significant barriers to access for insomnia treatment for children; most importantly, sleep interventions are often only provided by specialists, limiting access to treatment services. Instead, behavioural insomnia is often treated with advice about sleep hygiene and with the supplement melatonin, which is, at best, a short-term solution. The investigators, an interdisciplinary team of researchers, will develop and evaluate the effectiveness of an online sleep intervention that will be widely accessible and sustainable and will have the potential to dramatically improve the health of children with NDD and their families.

NCT ID: NCT02448602 Recruiting - Primary Insomnia Clinical Trials

Different Acupoints Compatibility Difference of the Effect of Treatment of the Primary Insomnia

Start date: January 2015
Phase: Phase 1
Study type: Interventional

With primary insomnia as the research object, by the method of multi-center RCT and needle single cavity and different acupoints compatibility treatment for primary insomnia, to Pittsburgh sleep quality index(PSQI) and evaluation, sleep log evaluation and Polysomnogram(PSG) as the means, such as the single cavity with different acupoints compatibility evaluate clinical curative effect of treating primary insomnia.

NCT ID: NCT02443649 Completed - Primary Insomnia Clinical Trials

Improving Sleep Quality in People With Insomnia

Start date: January 2015
Phase: N/A
Study type: Interventional

Insomnia is a significant problem affecting 10 to 20% of US population. Long-term pharmacological treatments are not recommended due to side effects, with therapy and sleep hygiene education often employed as alternatives. Use of mind-body approaches for insomnia is increasing. One of the most promising mind-body approaches for alleviating sleep problems is hypnosis. Research indicates significant beneficial effects of hypnosis on sleep, but sleep was rarely assessed as primary outcome and studied populations were diverse. Further, it remains unclear who the best candidates for benefitting from hypnosis are. To address some of the gaps in the current knowledge, the study evaluates whether 1) an addition of hypnotic suggestion for sleep improvement to the optimizing sleep hygiene (OSH) program increases the effectiveness of the OSH using objective and subjective assessments and 2) determines characteristics associated with hypnotic responsiveness.To address these goals a randomized controlled trial (RCT) with 3 laboratory visits (baseline, intervention, and 1 month follow-up) will be conducted with 50 adults meeting criteria for primary insomnia and allocated to one the two groups: 1) experimental group receiving during the intervention visit a combination of the Optimizing Sleep Hygiene (OSH) program and a hypnosis session for sleep improvement and 2) a control group receiving at the intervention visit the OSH only. Hypnosis session for sleep improvement for the control group will be offered at the end of the follow-up study visit (conducted after 4 weeks post-intervention) after completing all follow-up measures. Each study visit will last for 2-3 hours. During the visits sleep, personality traits and daily function of the participants will be assessed. Further, after the baseline and one week before the follow-up visit subjects will wear a watch-like actigraphic device monitoring their sleep patterns at home and will complete sleep diary. The knowledge gained from this study will inform the literature and clinicians about usefulness of hypnosis for insomnia sufferers and will help identify the population of insomnia sufferers most likely benefit from use of hypnosis for sleep